Skip to content
Prime Gamble 870 offers in-depth casino reviews, betting ti…

Patients Discontinuing Anti-Obesity Medications Put On Weight Four Times Faster Than Those on Conventional Diets

Illustration of medical injection and weighing machine
Obesity treatment often requires long-term strategies.

Fresh analysis reveals that individuals who come off popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt traditional lifestyle regimens.

Research printed in a major health publication points out that while overweight people frequently drop about a fifth of their body weight while using the jabs, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"People purchasing such medications need to be cognizant of the potential of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

Such speed of regain implies a reversion to original weight in about one and a half years.

Comparing Approaches

The analysis, which examined 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.

Scientists point out that individuals who shed pounds through dieting usually see a less rapid creep back—around 0.1 kg a month—once they finish.

The Reason for the Quick Regain

Doctors propose the mechanism of the drugs explains the heightened weight return.

The injections mimic a body's own chemical called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone levels far above than normal could lead to the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication leads to hunger is uncontrolled, making overeating far more likely."

A Chronic Issue?

Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

Many experts say that, considering the likelihood of weight regain, the therapy is often life-long.

This opinion is supported by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," comparing it to managing diseases like hypertension.

User Experiences

Individuals who have come off the jabs describe a powerful return of cravings.

"It felt as if a switch activating and you become ravenous," described a patient.

This difficulty is compounded if users have not adopted permanent lifestyle or habit modifications during treatment.

Widespread Interest

Figures show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.

  • Use is more common among women than men.
  • The middle-aged demographic shows the greatest usage rates.
  • A large proportion obtain the medications through private healthcare rather than public health services.

Ultimately, researchers caution that while these medications are potent agents for weight loss, they are not a permanent cure and long-term success likely depends on integrated behavioural management.

About the author

John Escobar

Maya Sterling is a professional gambler and gaming analyst with over a decade of experience in online casinos and sports betting.

Prime Gamble 870

Type to search articles.